SCHEMBL7984201

SCHEMBL7984201

CC(C)(C)c1ccc(Cn2cnc3[nH]c(-c4ccccc4F)nc(=O)c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.44
KCNJ11 Q14654 1/20 0.44
CNOT7 Q9UIV1 2/20 0.40
PARN O95453 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 1/20 0.39
NR1H4 Q96RI1 3/20 0.39
ACP1 P24666 1/20 0.39
CXCR2 P25025 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
SCD O00767 1/20 0.36
NR1I2 O75469 1/20 0.36
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
P2RX7 Q99572 1/20 0.35
ADORA2B P29275 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974061 0.89 CNOT7 (0.42) CNOT7PARNKMT2AMEN1SMN1; SMN2
SCHEMBL7988188 0.89 CNOT7 (0.44) CNOT7PARNKMT2AMEN1SMN1; SMN2
SCHEMBL7974647 0.88 CNOT7 (0.51) CNOT7PARNKMT2AMEN1SMN1; SMN2
SCHEMBL7974492 0.85 ABCC8 (0.47) ABCC8KCNJ11CNOT7PARNKMT2A
SCHEMBL7984195 0.84 HPGD (0.45) ABCC8KCNJ11KMT2AMEN1SMN1; SMN2
SCHEMBL7987364 0.84 TNKS (0.46) ABCC8KCNJ11CNOT7PARNSMN1; SMN2
SCHEMBL7991661 0.83 ABCC8 (0.45) ABCC8KCNJ11CNOT7PARNKMT2A
SCHEMBL7992270 0.82 ABCC8 (0.43) ABCC8KCNJ11CNOT7PARNNR1H4
SCHEMBL7984880 0.82 P2RX7 (0.46) CNOT7PARNKMT2AMEN1SMN1; SMN2
SCHEMBL7974312 0.82 HPGD (0.45) CNOT7PARNKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed